Select Page

The latest report on “Diabetes Drug Market (Drug Type – Injectable Drugs, and Oral Drugs; Application – Type 1 Diabetes, and Type 2 Diabetes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025.” The global diabetes drug market is projected to grow at a CAGR of 5.3% over the forecast period of 2019-2025.

Ask for Sample Copy of Research Report with Table of Content @

Diabetes, also referred to as diabetes mellitus is a group of diseases that occurs when blood glucose in the body is too high. Blood glucose is important for health as it is a vital source of energy that contributes to building muscles and tissue and is also energy fuel for the brain. Insulin is a hormone secreted by the pancreas, that promotes glucose uptake from the food which is been utilized by the cells to produce energy. In some cases, the body is unable to produce insulin which is type 1 diabetes whereas when the body does not produce insulin or neither can use insulin well is type 2 diabetes While prediabetes is the case where blood glucose is higher than normal but not much high to be referred as diabetes. In pregnancy, some women may get diabetes, known as gestational diabetes. In all such cases, glucose stays in the bloodstream and doesn’t reach the cells which in turn may cause damage to kidneys, nerves, and eyes. Diabetes may also lead to stroke or heart diseases.

One of the major factors driving the growth of the market is the growing prevalence of diabetes worldwide. According to the WHO, 422 million adults have diabetes that’s one person in eleven and around 1.5 million death caused by diabetes. Furthermore, increasing awareness about diabetes and its treatment among all the age groups is another factor fuelling the growth of the market. On the other hand, improper diagnosis of diabetes type I and II and lack of knowledge about the treatment in low-income countries as well as high costs associated with the drugs may slow down the growth of the market. However, a rise in government as well as private sector initiatives, research, and innovations in technology for innovative drugs will have greater opportunities for the diabetes drug market.

Asia Pacific Dominates the Segment and Tends to Dominate the Market Over the Forecast Period

Geographically, the diabetes drug market can be segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific dominates the segment and tends to dominate the market over the forecast period. Change in lifestyle and rising prevalence of diabetes is the major factor boosting the market in this region. In North America, the market is presumed to grow substantially during the forecast period due to the huge diabetes patient pool and rising awareness among the people. Europe contributes to the market growth due to established and well-organized healthcare sector thereby driving the growth of the diabetes drug market.

Segment Covered

The report on the global diabetes drug market covers segments such as drug type and application. On the basis of drug type, the sub-markets include injectable drugs and oral drugs. On the basis of application, the sub-markets include type 1 diabetes, and type 2 diabetes.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

Companies Profiled:

The report provides profiles of the companies in the market such as Bayer Healthcare, Bristol-Myers Squibb, Eli Lilly and Company, Biocon Ltd, Piramal healthcare ltd, Novartis AG, GlaxoSmithKline, Dr. Reddy’s laboratories ltd, Ranbaxy laboratories ltd, Novo Nordisk, and other companies.

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the diabetes drug.

=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.